107 related articles for article (PubMed ID: 35806362)
21. Utility of Routine Post Kidney Transplant Anti-HLA Antibody Screening.
Salhi S; Congy-Jolivet N; Hebral AL; Esposito L; Vieu G; Milhès J; Kamar N; Del Bello A
Kidney Int Rep; 2024 May; 9(5):1343-1353. PubMed ID: 38707794
[TBL] [Abstract][Full Text] [Related]
22. Separating the Wheat from the Chaff among HLA-DQ Eplets.
Devriese M; Lemonnier FA; Lion J; Sayegh C; Fleury E; Shofstall C; Giraldo L; Fiachetti Q; Usureau C; Miyadera H; Toutirais O; Mooney N; Lowe D; Taupin JL
J Immunol; 2024 Jun; 212(12):1981-1991. PubMed ID: 38647382
[TBL] [Abstract][Full Text] [Related]
23. De Novo Donor-Specific Antibodies after Heart Transplantation: A Comprehensive Guide for Clinicians.
Marco I; López-Azor García JC; González Martín J; Severo Sánchez A; García-Cosío Carmena MD; Mancebo Sierra E; de Juan Bagudá J; Castrodeza Calvo J; Hernández Pérez FJ; Delgado JF
J Clin Med; 2023 Dec; 12(23):. PubMed ID: 38068526
[TBL] [Abstract][Full Text] [Related]
24. Precision transplant pathology.
Wood-Trageser MA; Xu Q; Zeevi A; Randhawa P; Lesniak D; Demetris AJ
Curr Opin Organ Transplant; 2020 Aug; 25(4):412-419. PubMed ID: 32520786
[TBL] [Abstract][Full Text] [Related]
25. HLA Eplet Mismatches in Kidney Transplantation: More Than Just Adding Things Up.
Sypek MP; Hughes P
Kidney Int Rep; 2021 Jun; 6(6):1500-1502. PubMed ID: 34169190
[No Abstract] [Full Text] [Related]
26. Harnessing Precision Medicine: HLA or Eplet Matching in Heart Transplantation.
Defilippis EM; Lacelle C; Garg S; Farr M
J Card Fail; 2024 Feb; 30(2):373-375. PubMed ID: 37890653
[No Abstract] [Full Text] [Related]
27. Discovery of cellular and genetic signatures of immune tolerance in kidney transplant recipients through single cell RNA sequencing analysis.
Bae H; Lee H; Ko EJ; Kim CD; Lee SH; Yang CW; Oh EJ; Chung BH
HLA; 2023 Sep; 102(3):316-330. PubMed ID: 37038287
[TBL] [Abstract][Full Text] [Related]
28. Prediction of intradialytic hypotension using pre-dialysis features-a deep learning-based artificial intelligence model.
Lee H; Moon SJ; Kim SW; Min JW; Park HS; Yoon HE; Kim YS; Kim HW; Yang CW; Chung S; Koh ES; Chung BH
Nephrol Dial Transplant; 2023 Sep; 38(10):2310-2320. PubMed ID: 37019834
[TBL] [Abstract][Full Text] [Related]
29. Impact of Low-Level Donor-Specific Anti-HLA Antibody on Posttransplant Clinical Outcomes in Kidney Transplant Recipients.
Lee H; Lee H; Eum SH; Ko EJ; Min JW; Oh EJ; Yang CW; Chung BH
Ann Lab Med; 2023 Jul; 43(4):364-374. PubMed ID: 36843405
[TBL] [Abstract][Full Text] [Related]
30. Transplant Immunobiology: Many Answers Raising Even More Questions.
Oltean M
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628854
[TBL] [Abstract][Full Text] [Related]
31. Progress in kidney transplantation: The role for systems immunology.
Johnson AC; Silva JAF; Kim SC; Larsen CP
Front Med (Lausanne); 2022; 9():1070385. PubMed ID: 36590970
[TBL] [Abstract][Full Text] [Related]
32. HLA-DQ eplet mismatch load may identify kidney transplant patients eligible for tacrolimus withdrawal without donor-specific antibody formation after mesenchymal stromal cell therapy.
Bezstarosti S; Meziyerh S; Reinders MEJ; Voogt-Bakker K; Groeneweg KE; Roelen DL; Kers J; de Fijter JW; Heidt S
HLA; 2023 Jul; 102(1):3-12. PubMed ID: 36841928
[TBL] [Abstract][Full Text] [Related]
33. Human leukocyte antigen epitope mismatch loads and the development of de novo donor-specific antibodies in cardiothoracic organ transplantation.
Bedford A; Jervis S; Worthington J; Lowe M; Poulton K
Int J Immunogenet; 2022 Feb; 49(1):30-38. PubMed ID: 34904369
[TBL] [Abstract][Full Text] [Related]
34. Impact of low tacrolimus exposure and high tacrolimus intra-patient variability on the development of
Mendoza Rojas A; Hesselink DA; van Besouw NM; Baan CC; van Gelder T
Expert Rev Clin Immunol; 2019 Dec; 15(12):1323-1331. PubMed ID: 31721605
[No Abstract] [Full Text] [Related]
35. Combined Analysis of HLA Class II Eplet Mismatch and Tacrolimus Levels for the Prediction of De Novo Donor Specific Antibody Development in Kidney Transplant Recipients.
Lee H; Min JW; Kang H; Lee H; Eum SH; Park Y; Yang CW; Chung BH; Oh EJ
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806362
[TBL] [Abstract][Full Text] [Related]
36. Class II Eplet Mismatch Modulates Tacrolimus Trough Levels Required to Prevent Donor-Specific Antibody Development.
Wiebe C; Rush DN; Nevins TE; Birk PE; Blydt-Hansen T; Gibson IW; Goldberg A; Ho J; Karpinski M; Pochinco D; Sharma A; Storsley L; Matas AJ; Nickerson PW
J Am Soc Nephrol; 2017 Nov; 28(11):3353-3362. PubMed ID: 28729289
[TBL] [Abstract][Full Text] [Related]
37. Impact of HLA Eplet Mismatch on De Novo Donor Specific Antibody Formation After Kidney Transplantation.
Yanyiam P; Kantachuvesiri S; Thammanichanond D
Transplant Proc; 2024 Apr; 56(3):515-520. PubMed ID: 38368130
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
